Acomplia: Miracle Diet Pill?

The experimental weight loss drug (acomplia) has now completed it’s second trial:

The drug, rimonabant, which the French company Sanofi-Aventis hopes to sell under the brand name Acomplia, trimmed nearly 16 pounds on average from people taking the optimal dose for two years, compared with 5.5 pounds for those who took dummy pills, doctors reported Tuesday at a cardiology conference.

The drug works differently to most other weight loss drugs:

Acomplia works in an entirely different way, by blocking a “pleasure center” in the brain, leading people to eat less and acting directly on fat cells to prevent weight gain. Company studies suggest it also might help people quit smoking.

However it appears Acomplia will suffer from the same scourge as virtually every other drug - adverse side effects.